- Home
- BB vs PRCT Comparison
BB vs PRCT Comparison
Compare BB & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BB | PRCT |
|---|---|---|
| Founded | 1984 | 2009 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.0B |
| IPO Year | 1997 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BB | PRCT |
|---|---|---|
| Price | $3.77 | $31.30 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 9 |
| Target Price | $4.98 | ★ $51.13 |
| AVG Volume (30 Days) | ★ 9.1M | 1.4M |
| Earning Date | 12-18-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $534,799,999.00 | $299,907,000.00 |
| Revenue This Year | $3.25 | $48.30 |
| Revenue Next Year | $7.91 | $29.44 |
| P/E Ratio | $104.64 | ★ N/A |
| Revenue Growth | N/A | ★ 50.07 |
| 52 Week Low | $2.80 | $27.80 |
| 52 Week High | $6.24 | $89.49 |
Technical Indicators
Market Signals| Indicator | BB | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 35.93 | 41.70 |
| Support Level | $3.71 | $31.78 |
| Resistance Level | $3.99 | $32.94 |
| Average True Range (ATR) | 0.17 | 1.45 |
| MACD | -0.04 | -0.38 |
| Stochastic Oscillator | 7.43 | 3.76 |
Price Performance
Historical ComparisonAbout BB BlackBerry Limited
BlackBerry, once known for being the world's largest smartphone manufacturer, is now exclusively a software provider with a stated goal of end-to-end secure communications for enterprises. The firm provides endpoint management and other secure communications software to enterprises, specializing in regulated industries like government and financial institutions. BlackBerry also has a sizable embedded software business primarily serving the automotive market, with some exposure to the industrial market.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.